NCT05486351

Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke

Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 318 (estimated)
• Sponsor: Instituto de Investigación Hospital Universitario La Paz · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is an observational, prospective, multicenter, cohort study in patients with cardioembolic stroke and previous oral or parenteral anticoagulant therapy. Patients in which anticoagulante therapy is mantained will be compared to those in which it is interrupted, in terms of stroke or systemic embolism and haemorrhagic transformation.

Detailed description

Observational, prospective, multicenter, cohort study in patients with recent cardioembolic stroke (\<24 hours) and previous oral or parenteral anticoagulant therapy (last dose recieved \<24hours) . Patients in which anticoagulante therapy is mantained will be compared to those in which it is interrupted. The decision to mantain or interrumpt the anticoagulant therapy is made by the treating physician as hospital protocol. Stroke recurrence, haemorrhagic transformation at 90 days are evalauted and also complication during the hospitalization and functional outcome.

Conditions

• Cardioembolic Stroke
• Anticoagulant Therapy
• Stroke Recurrence
• Haemorrhagic Transformation Stroke

Interventions

Type	Name	Description
OTHER	Observation	Patients are observed for stroke or systemic embolism and haemorrhagic transformation

Timeline

• Start date: 2021-03-05
• Primary completion: 2023-12-31
• Completion: 2023-12-31
• First posted: 2022-08-03
• Last updated: 2022-08-03

Locations

3 sites across 2 countries: France, Spain